Natera, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 2,206 | $152.18 | $335,709 | 139,280 | Apr 28, 2025 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale | 1,709 | $152.18 | $260,076 | 155,237 | Apr 28, 2025 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sale | 6,203 | $152.18 | $943,973 | 192,162 | Apr 28, 2025 |
| ROSENMAN HERM | — | Award / Grant | 164 | — | — | 66,062 | Apr 25, 2025 |
| HEALY JAMES | — | Award / Grant | 142 | — | — | 46,260 | Apr 25, 2025 |
| BOTHA ROELOF | — | Award / Grant | 185 | — | — | 4,103 | Apr 25, 2025 |
| Baynes Roy D. | — | Award / Grant | 116 | — | — | 16,015 | Apr 25, 2025 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sale | 194 | $152.46 | $29,577 | 75,557 | Apr 24, 2025 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Option Exercise | 1,521 | — | — | 77,078 | Apr 21, 2025 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Option Exercise | 3,386 | — | — | 200,029 | Apr 21, 2025 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale | 4 | $146.10 | $584 | 156,946 | Apr 21, 2025 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 292 | $145.54 | $42,498 | 141,490 | Apr 21, 2025 |
| Sheena Jonathan | — | Option Exercise | 190 | — | — | 255,439 | Apr 21, 2025 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 6 | $146.16 | $877 | 225,667 | Apr 20, 2025 |
| Sheena Jonathan | — | Sale | 300 | $135.24 | $40,572 | 255,349 | Apr 4, 2025 |
| Marcus Gail Boxer | — | Sale | 1,512 | $140.17 | $211,937 | 11,794 | Apr 1, 2025 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,291 | $139.78 | $180,456 | 143,491 | Apr 1, 2025 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sale | 8,027 | $140.20 | $1,125,385 | 201,999 | Apr 1, 2025 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sale | 68 | $138.36 | $9,408 | 75,557 | Mar 31, 2025 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,367 | $138.41 | $189,206 | 225,318 | Mar 28, 2025 |
| Bertagnolli Monica | — | Award / Grant | 2,877 | — | — | 2,877 | Mar 28, 2025 |
| Sheena Jonathan | — | Sale | 2,017 | $145.17 | $292,808 | 259,002 | Mar 18, 2025 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sale | 6,702 | $146.03 | $978,693 | 203,354 | Mar 17, 2025 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sale | 790 | $146.03 | $115,364 | 71,871 | Mar 17, 2025 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sale | 3 | $149.58 | $449 | 2,364,288 | Mar 17, 2025 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 2 | $149.74 | $299 | 224,185 | Mar 17, 2025 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,023 | $146.03 | $149,389 | 144,785 | Mar 17, 2025 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale | 2 | $149.58 | $299 | 157,289 | Mar 17, 2025 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sale | 1,000 | $145.37 | $145,370 | 2,414,415 | Mar 14, 2025 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Award / Grant | 2,032 | — | — | 72,661 | Mar 12, 2025 |
| Sheena Jonathan | — | Award / Grant | 411 | — | — | 261,200 | Mar 12, 2025 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Award / Grant | 1,740 | — | — | 225,113 | Mar 12, 2025 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Award / Grant | 2,040 | — | — | 145,808 | Mar 12, 2025 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Award / Grant | 2,040 | — | — | 158,084 | Mar 12, 2025 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Award / Grant | 6,702 | — | — | 210,056 | Mar 12, 2025 |
| Marcus Gail Boxer | — | Option Exercise | 4,000 | $7.86 | $31,440 | 13,704 | Mar 12, 2025 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,200 | $142.08 | $170,496 | 148,568 | Mar 5, 2025 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sale | 33,776 | $144.02 | $4,864,420 | 214,574 | Mar 5, 2025 |
| Sheena Jonathan | — | Sale | 50 | $155.81 | $7,791 | 263,439 | Feb 26, 2025 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Award / Grant | 1,675 | — | — | 149,878 | Feb 6, 2025 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale | 663 | $177.77 | $117,862 | 156,044 | Feb 5, 2025 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Award / Grant | 36,682 | — | — | 290,626 | Jan 31, 2025 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sale | 3,500 | $175.39 | $613,865 | 110,631 | Jan 31, 2025 |
| Sheena Jonathan | — | Award / Grant | 3,549 | — | — | 263,489 | Jan 31, 2025 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Award / Grant | 29,345 | — | — | 2,412,522 | Jan 31, 2025 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Award / Grant | 10,353 | — | — | 223,373 | Jan 31, 2025 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Award / Grant | 12,720 | — | — | 148,203 | Jan 31, 2025 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Award / Grant | 11,832 | — | — | 155,032 | Jan 31, 2025 |
| ROSENMAN HERM | — | Award / Grant | 133 | — | — | 65,898 | Jan 31, 2025 |
| HEALY JAMES | — | Award / Grant | 114 | — | — | 46,118 | Jan 31, 2025 |